Capstone Holding

Capstone Holding Current Assets

The Current Assets of Capstone Holding (CAPS) as of Oct 27, 2026 is 18.14 M USD. In the previous year, Current Assets was 10.04 M USD — a change of 80.69% (higher).

Current Assets

18.14 MUSD

YoY

80.69%

Last updated:

Current Assets of Capstone Holding is 2025 18.14 M USD. Current Assets of Capstone Holding was 2024 10.04 M USD. It decreases by 80.69% higher compared to the previous year.

The Capstone Holding Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
1.44 M USD
Jan 1, 2019
284,000.00 USD
Jan 1, 2020
11.97 M USD
Jan 1, 2021
11.32 M USD
Jan 1, 2022
17.94 M USD
Jan 1, 2023
14.50 M USD
Jan 1, 2024
10.04 M USD
Jan 1, 2025
18.14 M USD
The Capstone Holding Current Assets history
YEARCurrent AssetsYoY
18.14 MUSD+80.69%
10.04 MUSD-30.78%
14.50 MUSD-19.17%
17.94 MUSD+58.53%
11.32 MUSD-5.49%
11.97 MUSD+4,116.20%
284,000.00USD-80.25%
1.44 MUSD+4.73%
1.37 MUSD+65.62%
829,000.00USD-34.10%
1.26 MUSD-53.73%
2.72 MUSD-58.11%
6.49 MUSD+1,594.78%
383,000.00USD-49.47%
758,000.00USD+17.88%
643,000.00USD-61.27%
1.66 MUSD+51.74%
1.09 MUSD+20.75%
906,000.00USD-53.54%
1.95 MUSD+127.54%
857,000.00USD-15.90%
1.02 MUSD-39.42%
1.68 MUSD-88.35%
14.43 MUSD-12.42%
16.48 MUSD-62.25%
43.66 MUSD-11.98%
49.60 MUSD-1.20%
50.20 MUSD-18.51%
61.60 MUSD-28.29%
85.90 MUSD+222.93%
26.60 MUSD+303.03%
6.60 MUSD-35.29%
10.20 MUSD+343.48%
2.30 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Capstone Holding Stock analysis

What does Capstone Holding do? Capstone Therapeutics Corp. is a biopharmaceutical company focused on the development of innovative therapeutic solutions for unmet medical needs. The company was founded in 1987 and is headquartered in Tempe, Arizona. It began as a research project at Arizona State University, eventually leading to the founding of the company. Capstone Therapeutics utilizes its technology platform in peptide chemistry, cell biology, and pharmacology to develop therapies for diseases with limited treatment options. Its core business includes developing medications for neurodegenerative diseases like Alzheimer's and oncological diseases with no effective treatment options. The company collaborates with other industry leaders in biotechnology and holds a strong intellectual property position. Capstone Therapeutics aims to improve the lives of individuals with serious illnesses through its innovative products and strategic approach. Capstone Holding is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Capstone Holding stock

Current Assets of Capstone Holding is 18.14 M USD in 2025.

Current Assets of Capstone Holding changed from 10.04 M USD to 18.14 M USD, representing a 80.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Capstone Holding since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Capstone Holding historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Capstone Holding

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Capstone Holding